Cell Signaling Technology

PSMA2 Antibody

#2455 · $317

100
Citing papers
29.4k
Combined citations
Supplier page Find this product

Research areas

Cancer Immunotherapy and Biomarkers25Immune Cell Function and Interaction9CAR-T cell therapy research9Cancer Cells and Metastasis7Immunotherapy and Immune Responses7Plant-Microbe Interactions and Immunity7Autophagy in Disease and Therapy7Cancer, Hypoxia, and Metabolism6

Papers citing this product

1
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
New England Journal of Medicine·2014·3.5k cit.·DOI
2
Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs
Nature Communications·2015·984 cit.·DOI
3
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy
Human Molecular Genetics·2010·895 cit.·DOI
4
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
JAMA Oncology·2015·834 cit.·DOI
5
Macronuclear Genome Sequence of the Ciliate Tetrahymena thermophila, a Model Eukaryote
PLoS Biology·2006·796 cit.·DOI
6
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
Journal of Neuroscience·2011·653 cit.·DOI
7
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Journal of Clinical Investigation·2018·598 cit.·DOI
8
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma
Science Translational Medicine·2015·566 cit.·DOI
9
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
Nature Communications·2018·558 cit.·DOI
10
Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37
The Journal of Immunology·2006·556 cit.·DOI

Similar products

ProductVendorPricePapers
PSMA2 (D3A4) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$16174